Michigan Diabetes Research and Training Center

2014-15 Pilot and Feasibility Study (P/FS) Program Guidelines

ELIGIBILITY

Individuals who have full-time instructional, clinical, or research faculty positions at the University of Michigan or the Centers regional partner institutions (Michigan State University, Wayne State University or the University of Toledo) are eligible to apply as Principal Investigators of P/FS grant proposals. Biomedical and type 1 translational researchers at the University of Michigan faculty or at a regional partner institution may apply for funding through the Michigan Diabetes Research Center (MDRC, PI Martin G. Myers Jr., MD, PhD). Type 2 translational studies are restricted to researchers at the University of Michigan who may apply for funding through the Michigan Center for Diabetes Translational Research (MCDTR; PI William H. Herman, MD, MPH). Grant proposals should address key questions in the pathogenesis, diagnosis, prevention, or control of diabetes, its complications, or related endocrine or metabolic disorders (for example: counter-regulatory proteins, obesity, metabolic syndrome).

Eligible applicants must be: a) new investigators beginning careers in diabetes-related research (i.e. research relevant to diabetes, its complications, or related endocrine and metabolic disorders); b) established investigators in areas other than diabetes who wish to focus their expertise on a problem in diabetes-related research; or c) established investigators in diabetes-related research who wish to take an entirely new direction in their diabetes-related research. This new direction cannot be an extension of the research currently being undertaken by the applicant.

APPLICATIONS

Proposals should be for one year of support, with requested funding up to $50,000 direct costs. P/FS funds may be requested for supplies or salary support for a study coordinator, research assistant or trainee. Up to $10,000 can be used for salary support for young clinical investigators doing T2 translational (bedside to community or epidemiological) research. Funds may not be applied to salary support for senior Principal Investigators or Principal Investigators doing biomedical or T1 clinical (bench to bedside) research, or for travel expenses or purchase of equipment (i.e., durable items costing over $5000).

Each proposal will receive peer review by a group of recognized experts in the area of the proposal from the United States and abroad. It is anticipated that P/FS projects that receive a favorable review will be funded in January 2015.

Applications must be prepared using the 2014-15 MDRC/MCDTR P/F application. The application form may be downloaded below.

Proposals should be for one year of support, with requested funding up to $50,000.

Application Due Date: Monday August 4, 2014 (5 PM)

MDRTC/MCDTR PILOT and FEASIBILITY AWARD TERMS

  1. Awardees are required to inform the awarding Center if the P/FS grant receives external funding during the project period.
  2. A final progress report is due one month after the close of the project period. The one page report must contain a synopsis of scientific progress; a list of resulting collaborations, publications, grants; and a description of the relationship of the project to core use.
  3. For the following five years, awardees must provide annual updates concerning other support, publications, and research activities directly related to the P/FS grant award, even if they leave the institution.
  4. Biomedical and type 1 translational researcher awardees must attend the MDRC Annual Symposium (generally held in March or April each year) and present a poster on their research.
  5. Publications resulting from the MDRC funding must acknowledge grant support: NIH P30DK020572. Publications resulting from MCDTR funding must acknowledge grant support: NIH P30DK092926.
  6. Publications that utilized core facilities of either the MDRC or MCDTR must acknowledge grant support from the appropriate Center as follows:
    “This work utilized ____ Core(s) of the Michigan Diabetes Research Center funded by NIH P30DK020572 from the National Institute of Diabetes and Digestive and Kidney Diseases.”
    or
    “This work utilized the ____ Core(s) of the Michigan Center for Diabetes Translational Research funded by NIH P30DK092926 from the National Institute of Diabetes and Digestive and Kidney Diseases.”

To access the cover letter and application form, please provide us with the following information:

Please select your affiliation:
I am a University of Michigan faculty member (must enter U-M email below)
I am a faculty member of Michigan State University, Wayne State University
or University of Toledo
Please enter your full name:
Please enter your email address: